The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...

Eli Lilly plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on Thursday, ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

The deal returns the drug-maker to the growing market for obesity drugs after scrapping an experimental weight-loss pill.

Though the trial for patients with obesity and type 2 diabetes will come to an end, an obesity-only trial will continue.

If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs ...

Eli Lilly (NYSE:LLY) has decided to stop one of its obesity drug combination trials, pressing pause on a study that paired ...

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially preventing cancer and autoimmune diseases.

Some women are experiencing significant hair loss as a side effect of testosterone therapy and popular weight-loss drugs. Rapid weight loss from GLP-1 medications like Ozempic and Zepbound can trigger ...

Excellus BlueCross BlueShield is pushing back against reports that it will no longer cover GLP-1 medications, saying drugs ...

Serena Williams reflected on the 'difficult August' she had following the backlash she received for taking weight-loss medications.